AmoyDx(SZ:300685) Xin Lang Cai Jing·2026-01-13 03:37Group 1 - The core viewpoint of the news is that Aide Biological has seen a significant increase in its stock price, rising 5.23% to 22.95 CNY per share, with a total market capitalization of 8.986 billion CNY and a trading volume of 1.79 billion CNY [1] - Aide Biological specializes in the research, production, and sales of molecular diagnostic products for precision oncology, with its main revenue sources being testing reagents (83.43%), clinical research services (9.84%), and testing services (5.61%) [1] - The company has experienced a cumulative stock price increase of 4.06% over the past three days, indicating positive market sentiment [1] Group 2 - Among the top shareholders of Aide Biological, Huabao Fund's Huabao Zhongzheng Medical ETF (512170) reduced its holdings by 1.3344 million shares in the third quarter, now holding 7.7022 million shares, which is 1.98% of the circulating shares [2] - The Huabao Zhongzheng Medical ETF has achieved a year-to-date return of 12.08% and a one-year return of 25.54%, ranking 675 out of 5,517 and 3,238 out of 4,203 respectively in its category [2] - The fund manager, Hu Jie, has a tenure of 13 years and has managed a total asset size of 100.204 billion CNY, with the best fund return during his tenure being 173.62% [3]